BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,479,000 | -18.2% | 16,402 | -21.2% | 0.00% | 0.0% |
| Q2 2022 | $3,032,000 | 0.0% | 20,810 | -18.6% | 0.00% | 0.0% |
| Q1 2022 | $3,032,000 | -29.5% | 25,572 | -18.0% | 0.00% | -33.3% |
| Q4 2021 | $4,299,000 | -11.0% | 31,194 | -10.3% | 0.00% | 0.0% |
| Q3 2021 | $4,830,000 | +124.7% | 34,770 | +57.0% | 0.00% | +200.0% |
| Q2 2021 | $2,150,000 | -83.3% | 22,142 | -88.2% | 0.00% | -88.9% |
| Q1 2021 | $12,841,000 | +410.6% | 187,870 | +540.2% | 0.01% | +350.0% |
| Q4 2020 | $2,515,000 | +54.8% | 29,347 | +17.4% | 0.00% | +100.0% |
| Q3 2020 | $1,625,000 | -11.4% | 25,008 | -0.3% | 0.00% | -50.0% |
| Q2 2020 | $1,835,000 | +569.7% | 25,095 | +211.4% | 0.00% | – |
| Q1 2020 | $274,000 | -60.3% | 8,059 | -36.5% | 0.00% | -100.0% |
| Q4 2019 | $691,000 | +48.6% | 12,689 | +13.8% | 0.00% | – |
| Q3 2019 | $465,000 | +78.8% | 11,148 | +87.9% | 0.00% | – |
| Q2 2019 | $260,000 | -14.5% | 5,932 | +0.4% | 0.00% | – |
| Q1 2019 | $304,000 | +48.3% | 5,911 | +6.7% | 0.00% | – |
| Q4 2018 | $205,000 | -3.3% | 5,540 | -1.8% | 0.00% | – |
| Q3 2018 | $212,000 | 0.0% | 5,639 | +5.1% | 0.00% | – |
| Q2 2018 | $212,000 | – | 5,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |